Pharmacovigilance assessment of the association between Fournier’s gangrene and other severe genital adverse events with SGLT-2 inhibitors
Gian Paolo Fadini, Mayur Sarangdhar, Fabrizio De Ponti, Angelo Avogaro, Emanuel Raschi
BMJ Open Diabetes Research and Care Oct 2019, 7 (1) e000725; DOI: 10.1136/bmjdrc-2019-000725